(Q39843123)

15 September 2017

1 reference

title

Thalidomide and congeners as anti-inflammatory agents (English)

1 reference

15 September 2017

0 references

0 references

Koch HP

1

1 reference

15 September 2017

1 January 1985

1 reference

Progress in medicinal chemistry

15 September 2017

1 reference

15 September 2017

22

1 reference

15 September 2017

165-242

1 reference

The Thalidomide Tragedy in Germany: The End of a Historic Medicolegal Trial

15 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Die Thalidomid-Embryopathie*

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

1 reference

7 January 2021

Neuropathy after intake of thalidomide (distaval)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

[Does thalidomide (contergan) cause injurious effects?]

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

[Polyneuritic syndrome after prolonged thalidomide medication.]

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide neuropathy: a clinical electrophysiological, and histological follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

BLOOD PYRUVIC ACID IN THALIDOMIDE NEUROPATHY

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Unmyelinated nerve fibers in senile nerves and in late thalidomide neuropathy: a quantitative electron microscopic study (author's transl)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Neurological effects of glutethimide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Persistent neuropathy following chronic use of glutethimide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Antithyroid activity of N-phthalyl glutamic acid imide (K17)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The effect of thalidomide and its derivatives on thyroxine-induced metamorphosis of tadpole

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Effect of Thalidomide on the Graft versus Host Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Effect of thalidomide on the immunological response in local lymph nodes after a skin homograft.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Immunosuppression by thalidomide: implications for teratology

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

[Chromosome anomalies caused by surplus (trisomies) and age of the mother]

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Effect of thalidomide on survival of skin homografts in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Immunosuppression by cyclic imides in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Another chance for thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The effect of thalidomide on skin allografts in mice: survival of the grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Failure of thalidomide to influence homograft immunity in chickens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

New Methods of Treatment for Renal Allotransplant Using the Baboon as a Primate Experimental Model

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Assessment of paracervical nerve block anaesthesia during labour.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Effect of thalidomide on the antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Effects of thalidomide and its derivatives on human leucocytes cultured in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The immuno-suppressive effect of thalidomide in experimental tuberculosis in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Another chance for thalidomide?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Effect of thalidomide on rat liver regeneration and diaphragm carbohydrate metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Effect of transplanted tumor and various agents on liver regeneration during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

THALIDOMIDE (N-PHTHALOYLGLUTAMIMIDE) IN THE TREATMENT OF ADVANCED CANCER.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

CLINICAL EXPERIENCES WITH THALIDOMIDE IN PATIENTS WITH CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

STUDIES ON THE POSSIBLE ANTI-NEOPLASTIC EFFECT OF THALIDOMIDE

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

THALIDOMIDE: EFFECTS ON EHRLICH ASCITES TUMOR CELLS IN VITRO

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Negative Effect of Thalidomide and Relative Substances on the Growth of HeLa Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Cytological effects of thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide metabolite inhibits tumor cell attachment to concanavalin A coated surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Potentiating effect of thalidomide on methylcholanthrene oncogenesis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide and Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Tumour-incidence in progeny of thalidomide-treated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Analgesia Enhancing Effect of Thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Inhibition of Human Prolyl Hydroxylase as Common Biochemical Denominator of the Non-Sedative Effects of Thalidomide in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Hypothetical explanation of the embryotoxic action of thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The use of corticosteroids in leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Recent advances and present trends in leprosy research

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The diagnosis and treatment of leprosy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Leprosy reactional states and their treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

A classification of leprosy for research purposes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Further Observation with Thalidomide in Lepra Reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Recent experience with thalidomide in Hansen's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide in lepra reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Treatment of Moderately Severe Erythema Nodosum Leprosum with Thalidomide - A Double-blind Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide in the treatment of erythema nodosum leprosum. With a note on selected laboratory abnormalities in erythema nodosum leprosum.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Treatment of erythema nodosum leprosum with thalidomide.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Iridocyclitis in Lepra Reaction Treated with Thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Treatment of erythema nodosum leprosum with thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Letter: Thalidomine neuropathy and leprous neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Did thalidomide promote poliomyelitis following oral poliovirus vaccination in West Berlin in 1960?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Fatal Reaction to Dapsone During Treatment of Leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Letter: Thalidomide in erythema nodosum leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Erythema nodosum leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Letter: Thalidomide in erythema nodosum leprosum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Hansenosis of the neurotrophic type

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Incidations for thalidomide therapy for leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Therapy of tropical skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Leprosy and its chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide treatment of subacute cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide and the management of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Pharmacologic control of pruritus.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

In vivo measurements of iron, copper and zinc in the skin of prurigo nodularis patients treated with thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide in the treatment of actinic prurigo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Actinic prurigo, a variety of polymorphous light eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Actinic prurigo (Hutchinson's summer prurigo)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide in actinic prurigo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide in the Treatment of Recurrent, Necrotic, and Giant Mucocutaneous Aphthae and Aphthosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide in the treatment of Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Inhibition of PMN leukocytes chemotaxis by thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Thalidomide in Weber-Christian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Treatment of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

STUDIES ON THE DRUGS FOR PEPTIC ULCER. A RELIABLE METHOD FOR PRODUCING STRESS ULCER IN RATS

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Treatment of ulcerative colitis with thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Immunofluorescence studies in reactional leprosy with relevance to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The arthus reaction in rats, a possible test for anti-inflammatory and antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Effects of thalidomide on the generation of oxygen intermediates by zymosan-stimulated normal polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Another chance for thalidomide?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

B Lymphocytes in Lepromatous Leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Teratogenesis and lymphocyte stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The effect of glutaric acid imide (Bemegride, Glutethimide) on the blood of hens

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

A CYTOSPECTROPHOTOMETRIC INVESTIGATION OF THE ACTION OF THALIDOMIDE ON THE NUCLEUS OF A LYMPHOCYTE.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

CHROMOSOME ABERRATIONS IN HUMAN CELLS INDUCED BY THALIDOMIDE IN VITRO: PRELIMINARY REPORT

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Serum macrophage migration inhibition activity in patients with leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

On Characteristic Antiinflammatory Effects of Several Antileprosy Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Serum and tissue lysozyme in leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Trials with Thalidomide Derivatives in Leprosy Reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Study with nine thalidomide derivatives in the lepra reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Teratologic-neurotoxicologic studies on biglumide (K-2004) and thalidomide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

[Morphological changes of the pituitary gland and adrenal cortex in rats after application of hormonally active substances for the treatment of DMBA-induced mammary tumors]

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Clinical trial of the cyclic imide 1-(morpholinomethyl)-4-phtalimido-piperidindione-2,6 (CG 603) in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Synthesis and anticancer activity of asparagine analogs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Potential Anticancer Agents. III. 2-Phthalimidoaldehydes and Derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Analogs of the abortifacient aminoglutethimide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

The influence of an anti-steroidogenic drug (aminoglutethimide phosphate) on pregnancy maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Irreversible Effects of Glutethimide Addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

Teratology study of two isoglutamine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

DERIVATIVES OF GLUTARIMIDE LIKELY TO POSSESS THERAPEUTIC ACTIVITY

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

PHARMACOLOGICAL PROPERTIES AND TERATOGENIC ACTION OF 2-(HEXAHYDROPHTHALIMIDO) GLUTARIMIDE AND 2-PHTHALIMIDO-N-METHYLGLUTARIMIDE

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

A method for evaluating both non-narcotic and narcotic analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970231-5

7 January 2021

10.1016/S0079-6468(08)70231-5

Identifiers

DOI

0 references

PubMed ID

3915365

1 reference

PubMed ID

3915365